Endocrinology
Partner With Us
Advertisement
Conexiant chevron_right Endocrinology chevron_right Sugar Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes
From the Journals

Sugar-Sweetened Beverages May Raise Risk of  Hepatic Cancer Subtypes

In a pooled analysis of more than 1.5 million patients, sugar-sweetened beverages were associated with higher risks of HCC and ICC, while artificially-sweetened beverages showed no independent association with hepatic cancer.

Conexiant

Clinical Scorecard: Sugar-Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes

At a Glance

CategoryDetail
Condition
Key MechanismsHigher consumption of sugar-sweetened beverages is associated with increased risk of HCC and ICC.
Target Population
Care Setting

Key Highlights

  • Pooled analysis of over 1.5 million patients from 11 studies.
  • Each additional daily sugar-sweetened beverage linked to 10% higher likelihood of HCC and 15% higher likelihood of ICC.
  • Artificially-sweetened beverages showed no association with hepatic cancer risk.
  • Limitations include self-reported beverage consumption and incomplete data on liver disease.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider monitoring beverage intake based on study findings.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adults without a history of cancer.

        No specific treatment insights provided; focus on beverage consumption.

        Clinical Best Practices

        • Assess dietary habits in relation to cancer risk factors.

        Related Resources & Content

        Daily News

        Stay up to date with the latest clinical headlines and other information tailored to your specialty.